To: Old_Mil
I find it curious the company that developed zolpidem doesn't want to be involved in the testing on brain damaged patients. You would think that they would be shouting this from the rooftops (even though the drug is now available as a generic). Strange ...
To: JustaDumbBlonde
I find it curious the company that developed zolpidem doesn't want to be involved in the testing on brain damaged patients.
There are a lot of things that do or do not happen in the world of medicine and pharmaceuticals because of the chill effect of trial lawyers on the field, this may be one of them. Again, no guarantees, but it certainly is worth investigating.
61 posted on
09/11/2006 9:15:23 PM PDT by
Old_Mil
(http://www.constitutionparty.com/)
To: JustaDumbBlonde
The Guardian is often full of crap. I searched Yahoo for the drug name and I didn't see anything about this, although I only looked at a couple of pages because it is late.
I'll keep this thread up on my computer because I also want to look at it some more. Unfortunately it summons the cynic in me. One piece on it did mention that overdose might result in 'paradoxical insmonia.' It bears a further look.
64 posted on
09/11/2006 9:19:34 PM PDT by
sig226
(There are 10 kinds of people in the world: those who understand binary and those who do not.)
To: JustaDumbBlonde
I believe the story says the patent has run out and generics are available. Trials are vey time consuming and expensive and if you no longer have the patent on the drug, you probably wouldn't bother either.
To: JustaDumbBlonde
YOu figured that out: the drug is now available as a genetic.
So the pharma company is desperately working on a slight chemical variation for use in these patients that they can repatent and make gazillions on.
Now that there's anything wrong with that.
259 posted on
09/12/2006 5:32:55 AM PDT by
wouldntbprudent
(If you can: Contribute more (babies) to the next generation of God-fearing American Patriots!)
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson